Publikationen, an denen er mitarbeitet Susana Inmaculada Inoges Sancho (10)
2024
-
Dendritic Cells in Cancer Immunology and Immunotherapy
Cancers, Vol. 16, Núm. 5
2021
-
Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses
Emerging Microbes and Infections, Vol. 10, Núm. 1, pp. 1931-1946
2019
-
Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8+ T Cells
Cancer cell, Vol. 36, Núm. 6, pp. 613-629
-
Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
Nature Medicine, Vol. 25, Núm. 3, pp. 470-476
2018
-
Enhancement of antibody-dependent cellular cytotoxicity of cetuximab by a chimeric protein encompassing interleukin-15
OncoImmunology, Vol. 7, Núm. 2
-
Mitochondrial morphological and functional reprogramming following CD137 (4-1BB) Costimulation
Cancer Immunology Research, Vol. 6, Núm. 7, pp. 798-811
2017
-
A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
Journal of Translational Medicine, Vol. 15, Núm. 1
-
Antibody-dependent cell cytotoxicity: Immunotherapy strategies enhancing effector NK cells
Immunology and Cell Biology, Vol. 95, Núm. 4, pp. 347-355
2016
-
MRP1-CD28 bi-specific oligonucleotide aptamers: Target costimulation to drug-resistant melanoma cancer stem cells
Oncotarget, Vol. 7, Núm. 17, pp. 23182-23196
-
Tumor-Produced Interleukin-8 Attracts human myeloid-derived suppressor cells and elicits extrusion of Neutrophil Extracellular Traps (NETs)
Clinical Cancer Research, Vol. 22, Núm. 15, pp. 3924-3936